Isolated from Streptomyces caespitosus, mitomycin C (MMC) has various applications in the
management of corneal and external disease due to its ability to modulate cellular …

Mitomycin C is a chemotherapeutic agent that acts by inhibiting DNA synthesis. Its use and
application in ophthalmology has been increasing in recent years because of its modulatory …

Mitomycin (mitomycin C; MMC) is an antibiotic isolated from Streptomyces caespitosus. The
drug is a bioreductive alkylating agent that undergoes metabolic reductive activation, and …

Introduction to the use of Mitomycin C in ophthalmology was a significant development in the
1960s. Its use and application in ophthalmology has been increasing in recent years …

Mitomycin-C is a chemotherapeutic drug that acts by inhibiting DNA synthesis. Its use and
application in ophthalmology has been increasing in recent years because of its mandatory …

Mitomycin C is an alkylating agent with an anti-proliferative activity. Because of its potent anti-
fibroblastic effect, it is used in multiple ocular surgical procedures where inhibition of …

Mitomycin C (MMC) is a cytostatic agent topically used in conjunctival neoplasms,
secondary to glaucoma filtering, pterygium, and strabismus surgery to increase the success …

Interesting Medical Image| 287 the cornea. It is an active process associated with cell
growth, remodelling of the connective tissue, angiogenesis and inflammation, triggered by …

How and when to use mitomycin-C in refractive surgery : Current Opinion in Ophthalmology
How and when to use mitomycin-C in refractive surgery : Current Opinion in Ophthalmology Log …

Mitomycin-C, first found its way into ophthalmic use in 1969, in Japan, where recurrent
pterygia were successfully treated with the drug which is an antineoplastic/antibiotic agent …